LatestPuerto Rico Senate to Investigate Alleged Pressure in ADSEF Contract Signings
Cannabis

Los Angeles Mayoral Candidate Proposes Overhaul of Nation's Largest Cannabis Market

Chris Roberts
MJBizDaily
Summary

Los Angeles City Councilmember Nithya Raman, the leading mayoral candidate, has unveiled a comprehensive platform to address systemic problems in the city's cannabis market—the largest municipal market in the United States. Raman's proposal aims to streamline licensing processes, reduce regulatory barriers, and increase access to legal cannabis products while simultaneously undermining the illicit market that continues to dominate in Los Angeles. The initiative reflects growing recognition that poorly designed cannabis regulations can stifle legitimate businesses and undermine public health objectives. This development is significant for patients seeking reliable access to medical cannabis and those relying on standardized, tested products for therapeutic purposes.

MJ Biz Daily

Originally published on

MJBizDaily

By Chris Roberts

Read full article(opens in new tab)

Fetched: September 30, 2026 at 10:01 AM

More news you might be interested in

View all
Uruguay Reports 46% Increase in Pharmacy Cannabis Sales
Cannabis

Uruguay Reports 46% Increase in Pharmacy Cannabis Sales

Uruguay's regulated cannabis market is experiencing significant growth, with pharmacy dispensations increasing 46% between January and August compared to the same period in 2025. According to the director of Uruguay's cannabis regulatory institute (IRCCA), this expansion reflects greater integration of patients into the legal, regulated distribution system rather than reliance on unregulated sources. The surge demonstrates growing patient confidence in accessing quality-controlled cannabis products through official healthcare channels. This trend underscores the importance of regulated markets in providing safe, standardized cannabis products for patients with various therapeutic needs. Uruguay's model offers valuable insights for other Latin American jurisdictions, including Puerto Rico, considering medical cannabis legalization.

2 hours ago
Revista Cáñamo
Clinical Trial Compares Psilocin and Psilocybin Effects in Humans
Cannabis

Clinical Trial Compares Psilocin and Psilocybin Effects in Humans

A clinical trial with 20 healthy adults compared oral psilocin and psilocybin administration, along with various doses of sublingual psilocin. Results indicate that oral and sublingual psilocin produced similar subjective experiences to psilocybin, but with fewer adverse effects. This research provides valuable pharmacokinetic data on different administration routes and formulations of these psychoactive compounds. The findings suggest potential advantages for psilocin as a therapeutic option in future clinical applications, particularly regarding tolerability and safety profiles.

3 hours ago
Revista Cáñamo
Alcohol Consumption Becomes Critical Factor in Fatty Liver Disease Evaluation
Cannabis

Alcohol Consumption Becomes Critical Factor in Fatty Liver Disease Evaluation

The Spanish Association for the Study of the Liver emphasizes that assessing alcohol consumption must be integral to caring for patients with fatty liver disease. Rather than focusing solely on quantity consumed, specialists recommend evaluating drinking patterns and psychosocial factors that influence them. This comprehensive approach recognizes that fatty liver disease involves complex interactions between alcohol use, lifestyle, and mental health. For Puerto Rico patients, this means healthcare providers should conduct thorough discussions about drinking habits and underlying psychological factors when diagnosing and managing liver conditions. Early intervention based on complete alcohol assessment can improve treatment outcomes and prevent disease progression.

3 hours ago
Revista Cáñamo
DEA Judge Halts Marijuana Rescheduling Hearing Over Federal Process Gaps
Cannabis

DEA Judge Halts Marijuana Rescheduling Hearing Over Federal Process Gaps

A DEA administrative judge has paused proceedings on the Trump administration's marijuana rescheduling proposal after a federal watchdog report identified significant gaps in the government's evaluation process for controlled substances. The report raises concerns about the thoroughness and consistency of how federal agencies assess cannabis and other drugs for potential reclassification. The judge is now requesting input from DEA officials and hearing participants on how to address these procedural deficiencies. This pause may impact the timeline for potential cannabis rescheduling, which could affect medical access for patients with conditions treated using marijuana. The findings underscore ongoing scrutiny of federal cannabis policy and regulatory frameworks.

15 hours ago
Marijuana Moment